FIELD: chemistry.
SUBSTANCE: invention relates to compounds of general formulas Ia, Ib, IIa or IIb:
,
a pharmaceutical composition based thereon, as well as the use and method of imaging alpha-synuclein and for diagnosing diseases which are associated with alpha-synuclein aggregation.
EFFECT: obtaining novel compounds which are suitable for treating and preventing diseases associated with alpha-synuclein aggregation.
20 cl, 5 ex, 7 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
FURO[3,2-B]PYRAN DERIVATIVES, APPLICABLE IN SYNTHESIS OF ANALOGUES | 2011 |
|
RU2579511C2 |
N-SUBSTITUTED DERIVATIVES OF ANILINE SHOWING INHIBITORY EFFECT ON NO-SYNTHASE ACTIVITY, THERAPEUTIC AGENT BASED ON THEREOF, DERIVATIVES OF NITROPHENYLCARBOXYLIC ACID | 1995 |
|
RU2167858C2 |
COMPOUNDS SUITABLE FOR USE AS ATR KINASE INHIBITORS | 2014 |
|
RU2687276C2 |
RADIOLABELLED 2-AMINO-6-FLUORO-N-[5-FLUORO-PYRIDIN-3-YL]-PYRAZOLO [1, 5-A] PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES USED AS ATR KINASE INHIBITOR, PREPARATIONS BASED THEREON COMPOUNDS AND VARIOUS SOLID FORMS THEREOF | 2015 |
|
RU2719583C2 |
METHOD OF PRODUCING ATR KINASE INHIBITORS (EMBODIMENTS) | 2014 |
|
RU2720408C2 |
COMPOUNDS APPLICABLE AS ATR KINASE INHIBITORS | 2020 |
|
RU2750148C1 |
BENZIMIDAZOLE SULFONAMIDES DERIVATIVES AS INVERSE AGONISTS ASSOCIATED WITH RETINOIDS OF THE ORPHAN RECEPTOR GAMMA ROR GAMMA (T) | 2015 |
|
RU2738843C2 |
INSECTICIDE COMPOUNDS | 2008 |
|
RU2493148C2 |
TREATING OR PREVENTING PROLIFERATIVE CONDITIONS | 2010 |
|
RU2705548C2 |
USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
Authors
Dates
2024-07-08—Published
2020-11-19—Filed